180 related articles for article (PubMed ID: 15194334)
1. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients.
Hoppe L; Bressane R; Lago LS; Schiavo FL; Marroni CA; Keiserman DR; Brandão AB; Júnior AM; Cassal AP; Zanotelli ML; Cantisani GP
Transplant Proc; 2004 May; 36(4):961-3. PubMed ID: 15194334
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
[TBL] [Abstract][Full Text] [Related]
4. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia.
Kim JM; Kim SJ; Joh JW; Shin M; Moon JI; Jung GO; Choi GS; Kwon CH; Lee SK
Transplant Proc; 2010 Apr; 42(3):890-4. PubMed ID: 20430198
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
[TBL] [Abstract][Full Text] [Related]
6. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
[TBL] [Abstract][Full Text] [Related]
8. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
[TBL] [Abstract][Full Text] [Related]
9. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
10. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
Hadley S; Samore MH; Lewis WD; Jenkins RL; Karchmer AW; Hammer SM
Transplantation; 1995 Mar; 59(6):851-9. PubMed ID: 7535482
[TBL] [Abstract][Full Text] [Related]
11. Late cytomegalovirus disease following liver transplantation.
Shibolet O; Ilan Y; Kalish Y; Safadi R; Ashur Y; Eid A; Shouval D; Wolf D
Transpl Int; 2003 Dec; 16(12):861-5. PubMed ID: 12904846
[TBL] [Abstract][Full Text] [Related]
12. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
[TBL] [Abstract][Full Text] [Related]
13. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation.
Lianghui G; Shusen Z; Tingbo L; Yan S; Weilling W; Anwei L
Transplant Proc; 2004 Jun; 36(5):1502-5. PubMed ID: 15251371
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
Kim CK; Song JH; Kim SM; Peck KR; Oh W; Huh W; Kim YG; Kim SJ; Joh JW; Lee NY; Park CG; Hwang ES; Cha CY; Oh HY
Transplantation; 2003 Jun; 75(12):2151-5. PubMed ID: 12829929
[TBL] [Abstract][Full Text] [Related]
15. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection.
van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ
Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection and development of biliary complications after liver transplantation.
Halme L; Hockerstedt K; Lautenschlager I
Transplantation; 2003 Jun; 75(11):1853-8. PubMed ID: 12811245
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection of the liver transplant: virological, histological, immunological, and clinical observations.
Lautenschlager I; Halme L; Höckerstedt K; Krogerus L; Taskinen E
Transpl Infect Dis; 2006 Mar; 8(1):21-30. PubMed ID: 16623817
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of cytomegalovirus infection after living donor liver transplantation.
Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
